EUVIMEDEUVIMED entdecken
Crossref

Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis

Shivani Pathak, Vipendra Kumar Singh, Prashant Kumar Gupta, Arun Kumar Mahapatra, Rajanish Giri, Rashmi Sahu, Rohit Sharma, Neha Garg

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11081-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Shivani Pathak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, Ind…. Hauptthemen laut MEDLINE: Thalidomide, Prostatic Neoplasms, Receptors, Androgen, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PC) is among the most prevalent cancers in males. It is the leading cause of death in men, in around 48 out of 185 countries. Increased androgen receptor (AR) activity is the key factor contributing to the development or progression of newly diagnosed cases of prostate cancer. Over time, numerous compounds targeting AR have been identified, presenting encouraging avenues for suppressing its hyperactivity. In our investigation, we used the GEPIA tool to study the importance of AR in the context of prostate cancer. This tool integrates the data from TCGA and GTEx in the gene expression pattern analysis and their clinical relevance. This analysis evaluates overall survival, disease-free survival, and transcripts per million (TPM) analysis of AR in PC. We performed docking and simulation for FDA-approved anticancer drugs to assess their potential interactions with the AR. We also conducted a comprehensive analysis of drugs using a quantum calculation (DFT) which provides electronic properties, chemical reactivity, and stability using the HOMO-LUMO energy gap. This study suggests that repurposed synthetic anticancer drugs could be better options for treating prostate cancer by inhibiting AR. In this work, we have shown the potential of pomalidomide, a synthetic anticancer drug, as a potential candidate for androgen-dependent PC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThalidomideProstatic NeoplasmsReceptors, AndrogenAntineoplastic AgentsAndrogensMaleHumansMolecular Docking SimulationComputational Biology

Stichwörter der Autor:innen

Androgen receptorDrug repurposingFDA-approved drugsGEPIAMolecular dockingProstate cancerSimulation

Substanzen

ThalidomideReceptors, AndrogenpomalidomideAntineoplastic AgentsAndrogens

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.
  • School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, 175075, India.
  • Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, D.C., USA.
  • Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.
  • Department of Rasa Shastra & Bhaishjya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.
  • Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India. nehagarg@bhu.ac.in.

Zitieren

APA

Pathak, S., Singh, V. K., Gupta, P. K., Mahapatra, A. K., Giri, R., Sahu, R., Sharma, R., & Garg, N. (2025). Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis. Molecular Diversity. https://doi.org/10.1007/s11030-024-11081-7

Vancouver

Pathak S, Singh VK, Gupta PK, Mahapatra AK, Giri R, Sahu R, et al. Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis. Molecular Diversity. 2025. doi:10.1007/s11030-024-11081-7

BibTeX
@article{Pathak2025,
  author = {Pathak, Shivani and Singh, Vipendra Kumar and Gupta, Prashant Kumar and Mahapatra, Arun Kumar and Giri, Rajanish and Sahu, Rashmi and Sharma, Rohit and Garg, Neha},
  title = {Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11081-7}
}
Kostenlos starten →